Innovating Works

ZEPTO

Desconocido
ASSET: ASSET Analysing and Striking the Sensitivities of Embryonal Tumours BAYER SCHWEIZ AG participó en un FP7: Cancer is hallmarked by multiple genetic aberrations that lead to a functional derangement of cellular signalling networks. Embryonal tumour...
Financiado
ANGIOTOX: Histopathologic and Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities A Cross Sec... BAYER SCHWEIZ AG participó en un FP7: Inhibition of angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a well established therapeutic strategy aga...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.